PREVIEW MODE IS ENABLED
Skip to main content
Lippincott® Clinical Context
Administrator Resources
Faculty Resources
Health Library
Internal Medicine
Search menu toggle.
Type your search term
Select how to filter your search
Full Site
This Book
Search
Advanced Search
Log In
Sign In
Username
Password
I forgot my password?
Enter an Access Code
Sign in via:
Open Athens
|
Shibboleth
Menu toggle for mobile view.
Rotations
Texts
Video
Self Assessment
Video
Self Assessment
More Collections
Search Across Your Collections
Health Library Collections
Advanced Practice Nursing
Anatomical Sciences
Anesthesiology
Basic Sciences
Board Review Series
Cardiology
Ciencias Básicas
Clerkship
Cornerstone Pharmacy
Critical Care
Emergency Medicine
Exercise Science
Family Medicine
Integrated Basic and Anatomical Sciences
Integrated Pharmacy
International Anatomical Sciences
International Integrated Basic and Anatomical Sciences
International Premium Basic Sciences
Lippincott Advisor
Lippincott Illustrated Reviews
Made Incredibly Easy!
MD/DO Board Prep
Neurology
ObGyn
Occupational Therapy
Oncology
Ophthalmology
Orthopaedic Surgery
Osteopathic Medicine
PA Board Prep
PA Core Education
PA Rotations/Specialties
Pathology
Pediatrics
Physical Therapy
Premium Basic Sciences
Premium Pharmacy
Psychiatry
Speech, Language, Hearing
Surgery
Texts
Internal Medicine Evidence: The Practice-Changing Studies, 1e
Joshua M. Liao
,
Zahir Kanjee
,
Joel T. Katz
,
Joseph Loscalzo
,
Emily L. Aaronson
,
Erik L. Antonsen
,
Arjun K. Venkatesh
,
Luis Ticona
Buy Now in Print
Table of Contents
Table of Contents
Copyright
Dedication
Contributors
Preface
Acknowledgments
SECTION 1: Cardiology
p1-1
Expandable section
Add To
Remove From
Your Favorites
CHAPTER 1: Rate Versus Rhythm Control in Atrial Fibrillation: The AFFIRM Trial
p2-3
Add To
Remove From
Your Favorites
CHAPTER 2: Angioplasty Versus Streptokinase in Myocardial Infarction
p4-5
Add To
Remove From
Your Favorites
CHAPTER 3: First-Step Antihypertensive Therapy: The ALLHAT Trial
p6-7
Add To
Remove From
Your Favorites
CHAPTER 4: Heart Failure Treatment for African Americans: The A-HeFT Trial
p8-9
Add To
Remove From
Your Favorites
CHAPTER 5: Dual Antiplatelet Therapy in Non–ST-Elevation ACS: The CURE Trial
p10-11
Add To
Remove From
Your Favorites
CHAPTER 6: ACE Inhibitors in Congestive Heart Failure: The CONSENSUS Trial
p12-13
Add To
Remove From
Your Favorites
CHAPTER 7: CRT in Advanced Heart Failure: The COMPANION Trial
p14-15
Add To
Remove From
Your Favorites
CHAPTER 8: Beta Blockers in Chronic Heart Failure: The COMET Trial
p16-17
Add To
Remove From
Your Favorites
CHAPTER 9: Antiplatelet Therapy for Preventing Vascular Events
p18-19
Add To
Remove From
Your Favorites
CHAPTER 10: Statin Therapy After ACS: PROVE IT-TIMI 22
p20-21
Add To
Remove From
Your Favorites
CHAPTER 11: Transcatheter Aortic Valve Implantation: The PARTNER B Trial
p22-23
Add To
Remove From
Your Favorites
CHAPTER 12: Angioplasty Versus t-PA in Myocardial Infarction: The PAMI-1 Study
p24-25
Add To
Remove From
Your Favorites
CHAPTER 13: Aspirin and Thrombolysis in Myocardial Infarction: The ISIS-2 Trial
p26-27
Add To
Remove From
Your Favorites
CHAPTER 14: Heparin in ACS without ST Elevation
p28-29
Add To
Remove From
Your Favorites
CHAPTER 15: PCI Versus CABG for Severe CAD: The SYNTAX Trial
p30-31
Add To
Remove From
Your Favorites
CHAPTER 16: Antiarrhythmics and ICDs in CHF: The SCD-HeFT Trial
p32-33
Add To
Remove From
Your Favorites
CHAPTER 17: ACE Inhibitors in LV Dysfunction: The SAVE Trial
p34-35
Add To
Remove From
Your Favorites
CHAPTER 18: Dabigatran for Atrial Fibrillation: The RE-LY Trial
p36-37
Add To
Remove From
Your Favorites
CHAPTER 19: Spironolactone in Severe HF: The RALES Trial
p38-39
Add To
Remove From
Your Favorites
CHAPTER 20: Cholesterol Lowering in Coronary Artery Disease: The 4S Trial
p40-42
SECTION 2: Critical Care
p43-43
Expandable section
Add To
Remove From
Your Favorites
CHAPTER 21: Glucose Control in ICU Patients: The NICE-SUGAR Trial
p44-45
Add To
Remove From
Your Favorites
CHAPTER 22: Therapeutic Hypothermia after Cardiac Arrest: The HACA Trial
p46-47
Add To
Remove From
Your Favorites
CHAPTER 23: Corticosteroids in Septic Shock: The CORTICUS Trial
p48-49
Add To
Remove From
Your Favorites
CHAPTER 24: Low Tidal Volume Ventilation for Acute Respiratory Distress Syndrome: The Arma Trial
p50-51
Add To
Remove From
Your Favorites
CHAPTER 25: Timing of Antibiotics in Septic Shock
p52-53
Add To
Remove From
Your Favorites
CHAPTER 26: Paired Weaning Protocol for Mechanical Ventilation and Sedation: The ABC Trial
p54-55
Add To
Remove From
Your Favorites
CHAPTER 27: Blood Transfusion for ICU Patients: The TRICC Trial
p56-57
Add To
Remove From
Your Favorites
CHAPTER 28: Choice of First Vasopressor in Shock: The SOAP II Trial
p58-59
Add To
Remove From
Your Favorites
CHAPTER 29: Revascularization for Cardiogenic Shock After Myocardial Infarction: The Shock Trial
p60-61
Add To
Remove From
Your Favorites
CHAPTER 30: Early Goal-Directed Therapy in Sepsis
p62-63
Add To
Remove From
Your Favorites
CHAPTER 31: Prone Positioning in Severe ARDS: The PROSEVA Trial
p64-66
SECTION 3: Endocrinology
p67-67
Expandable section
Add To
Remove From
Your Favorites
CHAPTER 32: ACE Inhibitors for Diabetic Nephropathy
p68-69
Add To
Remove From
Your Favorites
CHAPTER 33: Bisphosphonates and Fracture Risk: The FIT Trial
p70-71
Add To
Remove From
Your Favorites
CHAPTER 34: Insulin Therapy and Diabetes Complications: The DCCT Trial
p72-73
Add To
Remove From
Your Favorites
CHAPTER 35: Hormone Replacement Therapy in Postmenopausal Women: The Women'S Health Initiative (WHI) Trial
p74-75
Add To
Remove From
Your Favorites
CHAPTER 36: Lifestyle Intervention and Metformin in Diabetes: The DPP Study
p76-78
SECTION 4: Gastroenterology
p79-79
Expandable section
Add To
Remove From
Your Favorites
CHAPTER 37: Antibiotics in Variceal GI Bleeding
p80-81
Add To
Remove From
Your Favorites
CHAPTER 38: Transfusion in UGIB
p82-83
Add To
Remove From
Your Favorites
CHAPTER 39: PPI Before Endoscopy in UGIB
p84-85
Add To
Remove From
Your Favorites
CHAPTER 40: Albumin in SBP
p86-87
Add To
Remove From
Your Favorites
CHAPTER 41: 10-Year Interval for Screening Colonoscopy
p88-89
Add To
Remove From
Your Favorites
CHAPTER 42: SAAG in the Diagnosis of Ascites
p90-91
Add To
Remove From
Your Favorites
CHAPTER 43: Rifaximin in Hepatic Encephalopathy
p92-93
Add To
Remove From
Your Favorites
CHAPTER 44: “Top-Down” Therapy for Crohn Disease
p94-96
SECTION 5: Hematology
p97-97
Expandable section
Add To
Remove From
Your Favorites
CHAPTER 45: Plasma Exchange in Thrombotic Thrombocytopenic Purpura
p98-99
Add To
Remove From
Your Favorites
CHAPTER 46: Natural History and Prognosis of MGUS
p100-101
Add To
Remove From
Your Favorites
CHAPTER 47: The
JAK2
Mutation in Myeloproliferative Neoplasms
p102-103
Add To
Remove From
Your Favorites
CHAPTER 48: Imatinib for CML
p104-105
Add To
Remove From
Your Favorites
CHAPTER 49: R-CHOP for Diffuse Large B-Cell Lymphoma: The GELA Trial
p106-107
Add To
Remove From
Your Favorites
CHAPTER 50: HiDAC as Consolidation Therapy for AML
p108-109
Add To
Remove From
Your Favorites
CHAPTER 51: ATRA Versus Chemotherapy for Acute Promyelocytic Leukemia
p110-111
Add To
Remove From
Your Favorites
CHAPTER 52: Bortezomib in Relapsed Multiple Myeloma: The APEX Trial
p112-113
Add To
Remove From
Your Favorites
CHAPTER 53: Optimal Therapy after First Complete Remission in AML
p114-115
Add To
Remove From
Your Favorites
CHAPTER 54: Genotype for Risk Stratification in Acute Myeloid Leukemia
p116-118
SECTION 6: Infectious Diseases
p119-119
Expandable section
Add To
Remove From
Your Favorites
CHAPTER 55: ART for Early Asymptomatic HIV: The START Study
p120-121
Add To
Remove From
Your Favorites
CHAPTER 56: Direct Acting Antivirals for HCV: The NEUTRINO and FISSION Trials
p122-123
Add To
Remove From
Your Favorites
CHAPTER 57: Antibiotic Monotherapy for Febrile Neutropenia
p124-125
Add To
Remove From
Your Favorites
CHAPTER 58: HIV Pre-exposure Chemoprophylaxis: The iPrEx Study
p126-127
Add To
Remove From
Your Favorites
CHAPTER 59: Oral Vancomycin For Severe
C. DIFFICILE
Infections
p128-129
Add To
Remove From
Your Favorites
CHAPTER 60: SMX-TMP for PCP Prophylaxis in AIDS
p130-131
Add To
Remove From
Your Favorites
CHAPTER 61: Combination ART for HIV
p132-133
Add To
Remove From
Your Favorites
CHAPTER 62: Early ART to Prevent HIV Transmission
p134-135
Add To
Remove From
Your Favorites
CHAPTER 63: Timing of ART with Acute OIs in HIV
p136-137
Add To
Remove From
Your Favorites
CHAPTER 64: Oseltamivir for Influenza
p138-140
SECTION 7: Nephrology
p141-141
Expandable section
Add To
Remove From
Your Favorites
CHAPTER 65: Intensity of Renal Replacement Therapy in the ICU
p142-143
Add To
Remove From
Your Favorites
CHAPTER 66: ACE Inhibitors in Chronic Nondiabetic Nephropathy: The REIN Trial
p144-145
Add To
Remove From
Your Favorites
CHAPTER 67: The MDRD Equation to Estimate GFR
p146-147
Add To
Remove From
Your Favorites
CHAPTER 68: High-Dose and High-Flux Membrane Use in Hemodialysis: The HEMO Study
p148-149
Add To
Remove From
Your Favorites
CHAPTER 69: Use of EPO in CKD: The CHOIR Trial
p150-151
Add To
Remove From
Your Favorites
CHAPTER 70: Renal Transplant Induction Regimen
p152-154
SECTION 8: Oncology
p155-155
Expandable section
Add To
Remove From
Your Favorites
CHAPTER 71: Prostatectomy Versus Watchful Waiting for Low-Risk Prostate Cancer: The SPCG-4 Trial
p156-157
Add To
Remove From
Your Favorites
CHAPTER 72: Low-Dose CT for Lung Cancer Screening: The NLST
p158-159
Add To
Remove From
Your Favorites
CHAPTER 73: Oxaliplatin as Adjuvant Therapy in Colon Cancer: The MOSAIC Trial
p160-161
Add To
Remove From
Your Favorites
CHAPTER 74: EGFR Inhibition in Non–Small-Cell Lung Cancer: The IPASS Trial
p162-163
Add To
Remove From
Your Favorites
CHAPTER 75: HER2-Targeted Therapy in Breast Cancer
p164-165
Add To
Remove From
Your Favorites
CHAPTER 76: Polypectomy to Prevent Colorectal Cancer: The National Polyp Study
p166-167
Add To
Remove From
Your Favorites
CHAPTER 77: Prevention of Recurrent VTE with LMWH in Patients with Cancer: The CLOT Trial
p168-169
Add To
Remove From
Your Favorites
CHAPTER 78: Breast-Conserving Surgery for Early Breast Cancer
p170-171
Add To
Remove From
Your Favorites
CHAPTER 79: Bevacizumab in Metastatic Colorectal Cancer Treatment
p172-173
Add To
Remove From
Your Favorites
CHAPTER 80: Aromatase Inhibitors in Early Breast Cancer
p174-176
SECTION 9: Pulmonology
p177-177
Expandable section
Add To
Remove From
Your Favorites
CHAPTER 81: The Wells Score for Pulmonary Embolism
p178-179
Add To
Remove From
Your Favorites
CHAPTER 82: Vena Caval Filters: The PREPIC Trial
p180-181
Add To
Remove From
Your Favorites
CHAPTER 83: Thrombolysis in Acute Pulmonary Embolism
p182-183
Add To
Remove From
Your Favorites
CHAPTER 84: Combination Long-Acting Beta Agonist and Inhaled Corticosteroid in COPD: The TORCH Trial
p184-185
Add To
Remove From
Your Favorites
CHAPTER 85: Dabigatran for The Treatment of Venous Thromboembolism: The RE-COVER Trial
p186-187
Add To
Remove From
Your Favorites
CHAPTER 86: Noninvasive Ventilation for COPD Exacerbations
p188-189
Add To
Remove From
Your Favorites
CHAPTER 87: LMWH for VTE Prophylaxis: The MEDENOX Trial
p190-191
Add To
Remove From
Your Favorites
CHAPTER 88: Light's Criteria for Pleural Effusions
p192-193
Add To
Remove From
Your Favorites
CHAPTER 89: Long-Acting Muscarinic Therapy in COPD
p194-195
Add To
Remove From
Your Favorites
CHAPTER 90: Inhaled Corticosteroids in COPD
p196-197
Add To
Remove From
Your Favorites
CHAPTER 91: Glucocorticoids for COPD Exacerbations
p198-199
Add To
Remove From
Your Favorites
CHAPTER 92: Dual Therapy in Asthma: The FACET Study
p200-201
Add To
Remove From
Your Favorites
CHAPTER 93: Targeting Molecular Defects in Cystic Fibrosis
p202-203
Add To
Remove From
Your Favorites
CHAPTER 94: Pirfenidone in IPF: The ASCEND Trial
p204-205
Add To
Remove From
Your Favorites
CHAPTER 95: Antibiotics in COPD Exacerbations
p206-208
SECTION 10: Rheumatology
p209-209
Expandable section
Add To
Remove From
Your Favorites
CHAPTER 96: Anti-TNFα Therapy in Rheumatoid Arthritis
p210-211
Add To
Remove From
Your Favorites
CHAPTER 97: Treatment of ANCA-Associated Vasculitis: The RAVE Trial
p212-213
Add To
Remove From
Your Favorites
CHAPTER 98: Hydroxychloroquine in SLE
p214-215
Add To
Remove From
Your Favorites
CHAPTER 99: Treatment Strategies in RA: The BeSt Study
p216-217
Add To
Remove From
Your Favorites
CHAPTER 100: Induction Treatment for Lupus Nephritis: The ALMS Trial
p218-220
×